Lung cancer is associated with a heavy cancer-related burden in terms of patients' physical
and mental health worldwide. Two randomized controlled trials, the US-National Lung …

Lung cancer remains the most significant cause of cancer death, accounting for about 20%
of all cancer-related mortality. A significant reason for this is delayed diagnosis, either due to …

Lung cancer is the leading cause of cancer deaths in Europe and around the world.
Although available therapies have undergone considerable development in the past …

Accounting for 28% of all cancer deaths and causing 1.3 million deaths worldwide every
year, lung cancer is the most lethal cancer. Diagnosing and treating cancer at its early …

Lung cancer remains the leading cause of cancer-related death in the United States.
Cigarette smoking is a well-recognized risk factor for lung cancer, and a sustained elevation …

Currently, the most effective way of reducing lung cancer mortality is early diagnosis of lung
cancer. The National Lung Screening Trial has proved the efficacy of lung cancer screening …

Early-stage treatment improves prognosis of lung cancer and two large randomized
controlled trials have shown that early detection with low-dose computed tomography …

Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Most patients with lung cancer are diagnosed when they present with symptoms, they have
advanced stage disease, and curative treatment is no longer an option. An effective …

Simple Summary Lung cancer management continues to evolve with improvements in
survival across all stages. The review highlights the current data supporting screening and …